Reviewed,
UniProtKB/Swiss-Prot P02741 (CRP_HUMAN)
Last modified
November 25, 2008.
Version 119.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: C-reactive protein Cleaved into the following chain: 1- Recommended name: C-reactive protein(1-205) | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 224 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Displays several functions associated with host defense: it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells. |
| Cofactor | Binds 2 calcium ions per subunit. |
| Subunit structure | Homopentamer. Pentaxin (or pentraxin) have a discoid arrangement of 5 non-covalently bound subunits. |
| Subcellular location | |
| Tissue specificity | Found in plasma. |
| Induction | The concentration of CRP in plasma increases greatly during acute phase response to tissue injury, infection or other inflammatory stimuli. It is induced by IL-1 and IL-6. |
| Miscellaneous | This protein owes its name to its ability precipitate pneumococcal C-polysaccharide in the presence of calcium. |
| Sequence similarities | Belongs to the pentaxin family. Contains 1 pentaxin domain. |
| Mass spectrometry | Molecular weight is 23028 Da from positions 19 - 224. Determined by MALDI. Ref.13 Molecular weight is 22930 Da from positions 19 - 223. Determined by MALDI. Ref.13 |
Ontologies
Keywords | |
|---|---|
| Biological process | Acute phase |
| Cellular component | Secreted |
| Coding sequence diversity | Alternative splicing |
| Domain | Signal |
| Ligand | Calcium Metal-binding |
| PTM | Pyrrolidone carboxylic acid |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | acute-phase response Inferred from electronic annotation. Source: UniProtKB-KW opsonizationTraceable author statement. Source: UniProtKB |
| Cellular component | extracellular region Non-traceable author statement. Source: UniProtKB |
| Molecular function | Gram-positive bacterial cell surface binding Traceable author statement. Source: UniProtKB calcium ion bindingInferred from electronic annotation. Source: UniProtKB-KW choline bindingTraceable author statement. Source: UniProtKB protein bindingInferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| FCGR2A | P12318 | 1 | EBI-1395983,EBI-1395970 | |
| FCGR2C | P31995 | 2 | EBI-1395983,EBI-1396036 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P02741-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P02741-2) The sequence of this isoform differs from the canonical sequence as follows: 67-199: Missing. | ||||||
| Notes: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 18 | 18 | ||||||||||||||||||||||||||||||||||||||||||||
| Chain | 19 – 224 | 206 | C-reactive protein | PRO_0000023526 | ||||||||||||||||||||||||||||||||||||||||||
| Chain | 19 – 223 | 205 | C-reactive protein(1-205) | PRO_0000023527 | ||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 19 – 224 | 206 | Pentaxin | |||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 78 | 1 | Calcium 1 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 79 | 1 | Calcium 1 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 156 | 1 | Calcium 1 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 156 | 1 | Calcium 2 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 157 | 1 | Calcium 1; via carbonyl oxygen | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 158 | 1 | Calcium 1 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 158 | 1 | Calcium 2 | |||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 168 | 1 | Calcium 2 | |||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Pyrrolidone carboxylic acid | |||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 54 ↔ 115 | |||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 67 – 199 | 133 | Missing in isoform 2. | VSP_004656 | ||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 49 | 1 | K → G AA sequence Ref.12 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 52 | 1 | T → G AA sequence Ref.12 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 67 – 82 | 16 | YSIFS…DNEIL → TVFSRMPPRDKTMRFF in CAA39671. Ref.4 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 80 – 98 | 19 | Missing AA sequence Ref.11 | |||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 170 | 1 | L → V in AAA52074. Ref.10 | |||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 25 – 29 | 5 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 37 – 40 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 48 – 58 | 11 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 61 – 63 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 67 – 73 | 7 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 86 | 7 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 87 – 89 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 90 – 95 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 98 – 103 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 112 – 119 | 8 | ||||||||||||||||||||||||||||||||||||||||||||
| Turn | 120 – 122 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 124 – 129 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 150 – 155 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 166 – 168 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 172 – 182 | 11 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 186 – 194 | 9 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 201 – 203 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Helix | 205 – 207 | 3 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 210 – 215 | 6 | ||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 217 – 220 | 4 | ||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Genomic DNA sequence for human C-reactive protein." Lei K.-J., Liu T., Zon G., Soravia E., Liu T.-Y., Goldman N.D. J. Biol. Chem. 260:13377-13383(1985) [PubMed: 2997165] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component." Woo P., Korenberg J.R., Whitehead A.S. J. Biol. Chem. 260:13384-13388(1985) [PubMed: 3840479] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Extrahepetic transcription of human C-reactive protein." Murphy T.M., Baum L., Beaman K. Submitted (NOV-1990) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | Tenchini M.L., Marchetti L., Bossi E., Malcovati M., Lorenzetti R. Submitted (MAY-1992) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [5] | "Controlled gene expression using acute phase response elements." Harraghy N. Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | SeattleSNPs program for genomic applications Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [7] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Liver. |
| [9] | "Biosynthesis and postsynthetic processing of human C-reactive protein." Tucci A., Goldberger G., Whitehead A.S., Kay R.M., Woods D.E., Colten H.R. J. Immunol. 131:2416-2419(1983) [PubMed: 6685157] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-26. |
| [10] | "Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1." Whitehead A.S., Bruns G.A.P., Markham A.F., Colten H.R., Woods D.E. Science 221:69-71(1983) [PubMed: 6857266] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 144-175. |
| [11] | "Primary structure of human C-reactive protein." Oliveira E.B., Gotschlich E.C., Liu T.-Y. J. Biol. Chem. 254:489-502(1979) [PubMed: 762075] [Abstract] Cited for: PROTEIN SEQUENCE OF 19-224. |
| [12] | "Partial amino-acid sequences of human and rabbit C-reactive proteins: homology with immunoglobulins and histocompatibility antigens." Osmand A.P., Gewurz H., Friedenson B. Proc. Natl. Acad. Sci. U.S.A. 74:1214-1218(1977) [PubMed: 403526] [Abstract] Cited for: PROTEIN SEQUENCE OF 22-55. |
| [13] | "Selected expression profiling of full-length proteins and their variants in human plasma." Kiernan U.A., Nedelkov D., Tubbs K.A., Niederkofler E.E., Nelson R.W. Clin. Proteomics 1:7-16(2004) Cited for: MASS SPECTROMETRY. |
| [14] | "Comparative analyses of pentraxins: implications for protomer assembly and ligand binding." Srinivasan N., White H.E., Emsley J., Wood S.P., Pepys M.B., Blundell T.L. Structure 2:1017-1027(1994) [PubMed: 7881902] [Abstract] Cited for: 3D-STRUCTURE MODELING. |
| [15] | "Three dimensional structure of human C-reactive protein." Shrive A.K., Cheetham G.M.T., Holden D., Myles D.A.A., Turnell W.G., Volanakis J.E., Pepys M.B., Bloomer A.C., Greenhough T.J. Nat. Struct. Biol. 3:346-353(1996) [PubMed: 8599761] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS). |
| [16] | "The physiological structure of human C-reactive protein and its complex with phosphocholine." Thompson D., Pepys M.B., Wood S.P. Structure 7:169-177(1999) [PubMed: 10368284] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS). |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia C-reactive protein entry |
| SeattleSNPs |
| Protein Spotlight No more Christmas pudding? - Issue 30 of January 2003 |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M11880 Genomic DNA. Translation: AAB59526.1. M11725 Genomic DNA. Translation: AAA52075.1. X56692 mRNA. Translation: CAA40020.1. X56214 mRNA. Translation: CAA39671.1. AF442818 Genomic DNA. Translation: AAL48218.2. AF449713 Genomic DNA. Translation: AAL40835.1. AL445528 Genomic DNA. Translation: CAH73654.1. AL445528 Genomic DNA. Translation: CAH73656.1. BC020766 mRNA. Translation: AAH20766.1. BC125135 mRNA. Translation: AAI25136.1. M35163 mRNA. Translation: AAA52076.1. K00518 mRNA. Translation: AAA52074.1. | |||||||||||||||||||||||||||||||
| PIR | CJHU. A24515. | ||||||||||||||||||||||||||||||
| RefSeq | NP_000558.2. | ||||||||||||||||||||||||||||||
| UniGene | Hs.695960 Hs.76452 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P02741. | ||||||||||||||||||||||||||||||
2-D gel databases | |||||||||||||||||||||||||||||||
| SWISS-2DPAGE | P02741. | ||||||||||||||||||||||||||||||
| DOSAC-COBS-2DPAGE | P02741. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PeptideAtlas | P02741. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENSG00000132693. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||
| GeneID | 1401. | ||||||||||||||||||||||||||||||

Clusters with